Keyword: brand-name drugs
News
23.03.2013
- The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...
News
15.05.2012
- AstraZeneca misled patent regulators more than a decade ago in a bid to block competition to its ulcer drug Losec, an adviser to Europe's top court said on Tuesday, backing a €52.5...
News
26.04.2012
- The Federal Trade Commission on Wednesday lost its latest attempt to thwart deals to delay the production of cheaper, generic drugs that brand-name drug companies make with...
